Inventor · disambiguated record
Thorsteinn Loftsson
Also filed as: LOFTSSON THORSTEINN
28 granted patents·13 pending applications·994 citations·filing 1983–2025
97Inventor score
Files withOCULIS OPERATIONS SARL14OCULIS EHF5KEY PHARMA4LIPID PHARMACEUTICALS EHF4LOFTSSON THORSTEINN4
Top patents by PatentIndex Score
41 records- 0197US5324718ACyclodextrin/drug complexationLOFTSSON THORSTEINN·Filed 1992·Granted Jun 28, 1994·243 cites·52 claims
- 0296US12233133B2Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient deliveryOCULIS OPERATIONS SARL·Filed 2023·Granted Feb 25, 2025·5 cites·29 claims
- 0396US12090160B2Stabilized dexamethasone compositionsOCULIS OPERATIONS SARL·Filed 2023·Granted Sep 17, 2024·4 cites·19 claims
- 0496US12090161B2Treatment of ocular inflammationOCULIS OPERATIONS SARL·Filed 2023·Granted Sep 17, 2024·2 cites·26 claims
- 0596US12090162B2Treatment of diabetic retinopathyOCULIS OPERATIONS SARL·Filed 2023·Granted Sep 17, 2024·3 cites·19 claims
- 0696US11135311B2Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient deliveryOCULIS EHF·Filed 2017·Granted Oct 5, 2021·16 cites·188 claims
- 0796US7893040B2Cyclodextrin nanotechnology for ophthalmic drug deliveryOCULIS EHF·Filed 2006·Granted Feb 22, 2011·91 cites·20 claims
- 0895US11491240B2Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient deliveryOculis SA·Filed 2021·Granted Nov 8, 2022·16 cites·360 claims
- 0995US8999953B2Cyclodextrin nanotechnology for ophthalmic drug deliveryOCULIS EHF·Filed 2013·Granted Apr 7, 2015·39 cites·20 claims
- 1095US8633172B2Cyclodextrin nanotechnology for ophthalmic drug deliveryLOFTSSON THORSTEINN·Filed 2013·Granted Jan 21, 2014·36 cites·20 claims
- 1194US12383565B2Treatment of diabetic retinopathy with ophthalmic compositionsOCULIS OPERATIONS SARL·Filed 2024·Granted Aug 12, 2025·1 cites·29 claims
- 1294US12097209B2Diabetic retinopathy treatment with stabilized dexamethasoneOCULIS OPERATIONS SARL·Filed 2020·Granted Sep 24, 2024·3 cites·27 claims
- 1394US5472954ACyclodextrin complexationCYCLOPS H F·Filed 1994·Granted Dec 5, 1995·257 cites·119 claims
- 1494US4859707ASulfur-substituted phenylacetamidesKEY PHARMA·Filed 1983·Granted Aug 22, 1989·37 cites·9 claims
- 1592US7115586B2Non-inclusion cyclodextrin complexesDECODE GENETICS EHF·Filed 2002·Granted Oct 3, 2006·48 cites·24 claims
- 1691US12403147B2Treatment of ocular inflammation following ocular surgeryOCULIS OPERATIONS SARL·Filed 2024·Granted Sep 2, 2025·0 cites·11 claims
- 1791US12403148B2PH stabilized ophthalmic compositionsOCULIS OPERATIONS SARL·Filed 2024·Granted Sep 2, 2025·0 cites·23 claims
- 1891US12397001B2Treatment of ocular inflammation with ophthalmic compositionsOCULIS OPERATIONS SARL·Filed 2024·Granted Aug 26, 2025·0 cites·23 claims
- 1991US12397002B2PH stabilized ophthalmic dexamethasone compositionsOCULIS OPERATIONS SARL·Filed 2024·Granted Aug 26, 2025·0 cites·18 claims
- 2091US12397000B2Stabilized ophthalmic dexamethasone compositionsOCULIS OPERATIONS SARL·Filed 2024·Granted Aug 26, 2025·0 cites·23 claims
- 2191US2025387411A1Ph stabilized ophthalmic compositionsOCULIS OPERATIONS SARL·Filed 2025·Application pending·0 cites
- 2286US4764381APercutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediolKEY PHARMA·Filed 1985·Granted Aug 16, 1988·66 cites·1 claims
- 2381US8372425B2Fatty acids for use as a medicamentLIPID PHARMACEUTICALS EHF·Filed 2009·Granted Feb 12, 2013·6 cites·10 claims
- 2479US2023042785A1Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient deliveryOculis SA·Filed 2022·Application pending·0 cites
- 2578US6699849B1Cyclodextrin complexes of benzodiazepinesCYCLOPS EHF·Filed 1999·Granted Mar 2, 2004·44 cites·50 claims
- 2678US2023037486A1Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient deliveryOculis SA·Filed 2022·Application pending·0 cites
- 2773US2024350557A1Free fatty acids and methods of manufacture and use for treating coronavirus and other viral respiratory infectionsLIPID PHARMACEUTICALS EHF·Filed 2024·Application pending·0 cites
- 2872US9072714B2Fatty acids for use as a medicamentLIPID PHARMACEUTICALS EHF·Filed 2013·Granted Jul 7, 2015·2 cites·3 claims
- 2967US4983396APercutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediolKEY PHARMA·Filed 1989·Granted Jan 8, 1991·30 cites·2 claims
- 3067US2024390515A1Multidose ophthalmic compositionsOCULIS OPERATIONS SARL·Filed 2024·Application pending·0 cites
- 3166US2024058358A1Ph stabilized topical ophthlamic compositionsOCULIS OPERATIONS SARL·Filed 2023·Application pending·0 cites
- 3265US12064455B2Free fatty acids and methods of manufacture and use for treating coronavirus and other viral respiratory infectionsLIPID PHARMACEUTICALS EHF·Filed 2021·Granted Aug 20, 2024·0 cites·30 claims
- 3364US4892737AComposition and method for enhancing permeability of topical drugsUNIV FLORIDA·Filed 1988·Granted Jan 9, 1990·28 cites·24 claims
- 3459US2012028944A1Cyclodextrin nanotechnology for ophthalmic drug deliveryLOFTSSON THORSTEINN·Filed 2011·Application pending·0 cites
- 3558US4885174APercutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediolKEY PHARMA·Filed 1988·Granted Dec 5, 1989·17 cites·3 claims
- 3653US2016346347A1Formation of cyclosporin a/cyclodextrin nanoparticlesOCULIS EHF·Filed 2016·Application pending·0 cites
- 3753US2018161449A1Formation of cyclosporin a/cyclodextrin nanoparticlesOCULIS EHF·Filed 2016·Application pending·0 cites
- 3852US2023263907A1Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient deliveryOculis SA·Filed 2021·Application pending·0 cites
- 3948US2014205650A1Coated suppositoriesLOFTSSON THORSTEINN·Filed 2012·Application pending·0 cites
- 4047US2004186075A1High-energy cyclodextrin complexesFiled 2004·Application pending·0 cites
- 4134US2004242538A1Method to improve complexation efficacy and produce high-energy cylodextrincomplexesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thorsteinn Loftsson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →